Italy In-Vitro Diagnostics Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
Italy In-Vitro Diagnostics Market will reach US$ 3.59 Billion in 2028, according to Renub Research. In vitro means ""in glass,"" indicating that the tests are conducted in controlled laboratory conditions rather than within a living organism. IVD, or In Vitro Diagnostics, are medical tests performed in a lab on samples like blood or urine. They help diagnose diseases, monitor treatment progress, and provide health information. IVD encompasses various tests like clinical chemistry, immunoassays, molecular diagnostics, microbiology, hematology, and histopathology. Common examples include glucose monitoring, cholesterol testing, pregnancy tests, HIV testing, genetic testing, and cancer biomarker analysis. IVD is vital for disease screening, early detection, patient management, and treatment monitoring, leading to improved outcomes and personalized medicine.
Italy In-Vitro Diagnostics Market shall grow at a CAGR of 6.65% during the forecast period of 2022 to 2028
The rising number of cases of chronic and infectious diseases and the aging population majorly add to Italy in-vitro diagnostics market growth. The publication titled ""cardiovascular disease (CVD) Burden: Italian and global perspectives,"" available on Europe PMC, highlighted that Italy exhibits a substantially higher prevalence of cardiovascular disease (CVD) in comparison to the global average. The report indicates that Italy CVD prevalence is nearly double the global average (12.9% vs. 6.6%), while age-standardized figures show relatively similar rates (6.2% vs. 6.3%).
Additionally, technological advancements, government initiatives, healthcare reforms, growing emphasis on personalized medicine, and increasing awareness and patient empowerment will further improve Italy in-vitro diagnostics market in the future. Hence, the market value for Italy's in-vitro Diagnostics Market was US$ 2.44 Billion in 2022.
Services shall thrive in the Italy in-vitro diagnostics market
Italy's in-vitro diagnostics market is categorized into three product segments: Services, Instruments, and Reagents. Services dominate the Italy in-vitro diagnostics market due to factors such as the complexity of IVD tests and devices, regulatory compliance, training and education needs, customization and integration services, and value-added support. With sophisticated technologies requiring specialized expertise, service providers are relied upon for proper handling and maintenance. In addition, strict regulations ensure patient safety and reliability, increasing the demand for technical services. Providers also offer training programs, customization, and additional support beyond installation and maintenance. These factors collectively drive the leadership of services in Italy in-vitro diagnostics market.
PCR tests shall continue to have the highest market share in the Italy in-vitro diagnostics market
In the Italy in-vitro diagnostics market, there is a range of test types available, including ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others.PCR tests are known for their high sensitivity and specificity, allowing for accurate detection and identification of pathogens or genetic material, contributing to their widespread adoption. PCR technology has many applications beyond infectious disease diagnosis, including genetics and forensics.
PCR tests offer relatively quick turnaround times and have the advantage of being available on various platforms, which facilitates scalability. Furthermore, PCR tests have a long-established track record of diagnostics validity and regulatory approval, which has instilled confidence in healthcare providers. Finally, the COVID-19 pandemic has played a central role in the widespread adoption of PCR tests, further contributing to their high share in the Italy in-vitro diagnostics market.
Infectious diseases application is fastest growing in the Italy In-vitro diagnostics market
In the Italy In-vitro diagnostics market, various applications are of significant importance, including Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and other applications. Increased global travel and migration have facilitated the spread of infectious diseases across borders, making Italy susceptible to their introduction and transmission. Additionally, changing demographics and lifestyle factors, such as urbanization, population density, and high-risk activities, contribute to transmitting infectious agents.
Antimicrobial resistance has also played a significant role, highlighting the need for accurate diagnostics to guide appropriate treatment decisions. Outbreaks and epidemics, such as influenza, measles, and COVID-19, have increased the demand for rapid and accurate diagnostics for timely intervention and public health management. Increased awareness and proactive screening programs have further contributed to the growth, as they help identify infected individuals early and initiate appropriate treatment. Technological advancements, including molecular diagnostics and rapid point-of-care testing, have improved infectious disease diagnostics' capabilities and accuracy, fuelling their market growth.
Molecular Diagnostics/Genetics shall flourish during the forecast period
In the Italy In-vitro diagnostics market, various technologies are utilized, including Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and other technologies. Technological advancements like PCR, NGS, and gene expression profiling have improved genetic testing accuracy and accessibility. A greater understanding of genetics in disease development has increased the demand for molecular diagnostics. Precision medicine tailors’ treatment based on genetics, biomarkers, and disease characteristics, contributing to growth.
In cancer diagnostics, molecular diagnostics enable early detection, accurate diagnosis, and personalized treatment plans. Government initiatives support molecular diagnostics adoption through research investment and reimbursement policies. The rising demand for early disease detection and prevention fuels molecular diagnostics growth in the market. These factors drive growth, enhancing diagnostics capabilities and personalized medicine approaches, especially in cancer diagnostics.
Hospitals continue to have sovereignty in the Italy In-vitro diagnostics market
Segmentation of Italy's in-vitro diagnostics market based on end-users can break into four divisions: Hospitals, Laboratories, Home-Care, and Other sectors. Hospitals dominate the Italy in-vitro diagnostics (IVD) market due to their comprehensive healthcare services and seamless integration of diagnostics with other specialties. They possess the necessary infrastructure, resources, and skilled personnel for a robust IVD operation.
Being primary points of care, hospitals offer a wide range of medical services and act as referral centers. Their diverse clinical specialties ensure accurate diagnosis and interpretation of IVD test results. In addition, hospitals benefit from favorable reimbursement and funding mechanisms and adhere to stringent regulatory requirements, ensuring patient safety and test accuracy.
Key Players
In the Italy in-vitro diagnostics market, notable companies include Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation.
In May 2022- The European Union's new In Vitro Diagnostic Regulation (EU) 2017/746 (IVDR) took effect in Italy on May 26, 2022. While some existing devices are granted transition periods, the IVDR requirements now apply to all new in vitro diagnostics (IVDs) and specific low-risk IVDs already available in the market.
Renub Research report titled “Italy in-vitro diagnostics Market Global Forecast by Products (Services, Instruments, and Reagents), Test Types (ELISA & CLIA, PCR, Rapid Test, Fluorescence Immunoassays (FIA), In Situ Hybridization, Transcription Mediated Amplification, Sequencing, Colorimetric Immunoassay, Radioimmunoassay (RIA), Isothermal Nucleic Acid Amplification Technology, and Others), Application (Infectious Diseases, Diabetes, Cardiology, Oncology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics/Genetics, Hematology, Microbiology, Coagulation, and Others), End-Users (Hospitals, Laboratories, Home - Care, and Others), Company Analysis (Roche Diagnostics, Abbott Diagnostics, Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, and Sysmex Corporation)"" provides a detailed analysis of Italy in-vitro Diagnostics Market.
Products - Market breakup from 3 Viewpoints:
1. Services
2. Instruments
3. Reagents
Test types - Market breakup from 11 Viewpoints:
1. ELISA & CLIA
2. PCR
3. Rapid Test
4. Fluorescence Immunoassays (FIA)
5. In Situ Hybridization
6. Transcription Mediated Amplification
7. Sequencing
8. Colorimetric Immunoassay
9. Radioimmunoassay (RIA)
10. Isothermal Nucleic Acid Amplification Technology
11. Others
Application - Market breakup from 8 Viewpoints:
1. Infectious Diseases
2. Diabetes
3. Cardiology
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Drug Testing
8. Others
Technology - Market breakup from 7 Viewpoints:
1. Immunoassay
2. Clinical Chemistry
3. Molecular Diagnostics/Genetics
4. Hematology
5. Microbiology
6. Coagulation
7. Others
End-Users - Market breakup from 4 Viewpoints:
1. Hospitals
2. Laboratories
3. Home – Care
4. Others
Company has been covered from 3 Viewpoints:
• Overview
• Recent Development
• Revenue
Company Analysis:
1. Roche Diagnostics
2. Abbott Diagnostics
3. Siemens Healthineers
4. Danaher Corporation
5. Thermo Fisher Scientific
6. Sysmex Corporation
- 1. Introduction
- 2. Research & Methodology
- 3. Executive Summary
- 4. Market Dynamic
- 4.1 Growth Drivers
- 4.2 Challenges
- 5. Porter’s Five Forces
- 5.1 Bargaining Power of Buyer
- 5.2 Bargaining Power of Supplier
- 5.3 Threat of New Entrants
- 5.4 Rivalry among Existing Competitors
- 5.5 Threat of Substitute Products
- 6. SWOT Analysis
- 6.1 Strengths
- 6.2 Weaknesses
- 6.3 Opportunities
- 6.4 Threats
- 7. Italy In-Vitro Diagnostics (IVD) Market
- 8. Market Share – Italy In-Vitro Diagnostics (IVD)
- 8.1 By Test Types
- 8.2 By Technology
- 8.3 By Products
- 8.4 By Application
- 8.5 By End User
- 9. Test Types –Italy In-Vitro Diagnostics (IVD) Market
- 9.1 ELISA & CLIA
- 9.2 PCR
- 9.3 Rapid Test
- 9.4 Fluorescence Immunoassays (FIA)
- 9.5 In Situ Hybridization
- 9.6 Transcription Mediated Amplification
- 9.7 Sequencing
- 9.8 Colorimetric Immunoassay
- 9.9 Radioimmunoassay (RIA)
- 9.10 Isothermal Nucleic Acid Amplification Technology
- 9.11 Others
- 10. Product Types – Italy In-Vitro Diagnostics (IVD) Market
- 10.1 Services
- 10.2 Instruments
- 10.3 Reagents
- 11. Technology – Italy In-Vitro Diagnostics (IVD) Market
- 11.1 Immunoassay
- 11.2 Clinical Chemistry
- 11.3 Molecular Diagnostics/Genetics
- 11.4 Hematology
- 11.5 Microbiology
- 11.6 Coagulation
- 11.7 Others
- 12. Application – Italy In-Vitro Diagnostics (IVD) Market
- 12.1 Infectious Disease
- 12.2 Diabetes
- 12.3 Cardiology
- 12.4 Oncology
- 12.5 Nephrology
- 12.6 Autoimmune Diseases
- 12.7 Drug Testing
- 12.8 Other Applications
- 13. End User – Italy In-Vitro Diagnostics (IVD) Market
- 13.1 Hospitals
- 13.2 Laboratories
- 13.3 Home - Care
- 13.4 Others
- 14. Government Rules & Regulation
- 15. Reimbursement
- 15.1 Public
- 15.2 Private & Insurance
- 16. Company Analysis
- 16.1 Roche Diagnostics
- 16.1.1 Overview
- 16.1.2 Resent Development
- 16.1.3 Revenue
- 16.2 Abbott Diagnostics
- 16.2.1 Overview
- 16.2.2 Resent Development
- 16.2.3 Revenue
- 16.3 Siemens Healthineers
- 16.3.1 Overview
- 16.3.2 Resent Development
- 16.3.3 Revenue
- 16.4 Danaher Corporation
- 16.4.1 Overview
- 16.4.2 Resent Development
- 16.4.3 Revenue
- 16.5 Thermo Fisher Scientific
- 16.5.1 Overview
- 16.5.2 Resent Development
- 16.5.3 Revenue
- 16.6 Sysmex Corporation
- 16.6.1 Overview
- 16.6.2 Resent Development
- 16.6.3 Revenue
- List of Figures:
- Figure-01: Italy – In-Vitro Diagnostics (IVD) Market (Billion US$), 2018 – 2022
- Figure-02: Italy – Forecast for In-Vitro Diagnostics (IVD) Market (Billion US$), 2023 – 2028
- Figure-03: Test Types – ELISA & CLIA Market (Million US$), 2018 – 2022
- Figure-04: Test Types – Forecast for ELISA & CLIA Market (Million US$), 2023 – 2028
- Figure-05: Test Types – PCR Market (Million US$), 2018 – 2022
- Figure-06: Test Types – Forecast for PCR Market (Million US$), 2023 – 2028
- Figure-07: Test Types – Rapid Test Market (Million US$), 2018 – 2022
- Figure-08: Test Types – Forecast for Rapid Test Market (Million US$), 2023 – 2028
- Figure-09: Test Types – Fluorescence Immunoassays (FIA) Market (Million US$), 2018 – 2022
- Figure-10: Test Types – Forecast for Fluorescence Immunoassays (FIA) Market (Million US$), 2023 – 2028
- Figure-11: Test Types – In Situ Hybridization Market (Million US$), 2018 – 2022
- Figure-12: Test Types – Forecast for In Situ Hybridization Market (Million US$), 2023 – 2028
- Figure-13: Test Types – Transcription Mediated Amplification Market (Million US$), 2018 – 2022
- Figure-14: Test Types – Forecast for Transcription Mediated Amplification Market (Million US$), 2023 – 2028
- Figure-15: Test Types – Sequencing Market (Million US$), 2018 – 2022
- Figure-16: Test Types – Forecast for Sequencing Market (Million US$), 2023 – 2028
- Figure-17: Test Types – Colorimetric Immunoassay Market (Million US$), 2018 – 2022
- Figure-18: Test Types – Forecast for Colorimetric Immunoassay Market (Million US$), 2023 – 2028
- Figure-19: Test Types – Radioimmunoassay (RIA) Market (Million US$), 2018 – 2022
- Figure-20: Test Types – Forecast for Radioimmunoassay (RIA) Market (Million US$), 2023 – 2028
- Figure-21: Test Types – Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2018 – 2022
- Figure-22: Test Types – Forecast for Isothermal Nucleic Acid Amplification Technology Market (Million US$), 2023 – 2028
- Figure-23: Test Types – Others Market (Million US$), 2018 – 2022
- Figure-24: Test Types – Forecast for Others Market (Million US$), 2023 – 2028
- Figure-25: Product Types – Services Market (Million US$), 2018 – 2022
- Figure-26: Product Types – Forecast for Services Market (Million US$), 2023 – 2028
- Figure-27: Product Types – Instruments Market (Million US$), 2018 – 2022
- Figure-28: Product Types – Forecast for Instruments Market (Million US$), 2023 – 2028
- Figure-29: Product Types – Reagents Market (Million US$), 2018 – 2022
- Figure-30: Product Types – Forecast for Reagents Market (Million US$), 2023 – 2028
- Figure-31: Technology – Immunoassay Market (Million US$), 2018 – 2022
- Figure-32: Technology – Forecast for Immunoassay Market (Million US$), 2023 – 2028
- Figure-33: Technology – Clinical Chemistry Market (Million US$), 2018 – 2022
- Figure-34: Technology – Forecast for Clinical Chemistry Market (Million US$), 2023 – 2028
- Figure-35: Technology – Molecular Diagnostics/Genetics Market (Million US$), 2018 – 2022
- Figure-36: Technology – Forecast for Molecular Diagnostics/Genetics Market (Million US$), 2023 – 2028
- Figure-37: Technology – Hematology Market (Million US$), 2018 – 2022
- Figure-38: Technology – Forecast for Hematology Market (Million US$), 2023 – 2028
- Figure-45: Technology – Microbiology Market (Million US$), 2018 – 2022
- Figure-46: Technology – Forecast for Microbiology Market (Million US$), 2023 – 2028
- Figure-39: Technology – Coagulation Market (Million US$), 2018 – 2022
- Figure-40: Technology – Forecast for Coagulation Market (Million US$), 2023 – 2028
- Figure-41: Technology – Others Market (Million US$), 2018 – 2022
- Figure-42: Technology – Forecast for Others Market (Million US$), 2023 – 2028
- Figure-43: Application – Infectious Disease Market (Million US$), 2018 – 2022
- Figure-44: Application – Forecast for Infectious Disease Market (Million US$), 2023 – 2028
- Figure-47: Application – Diabetes Market (Million US$), 2018 – 2022
- Figure-48: Application – Forecast for Diabetes Market (Million US$), 2023 – 2028
- Figure-49: Application – Cardiology Market (Million US$), 2018 – 2022
- Figure-50: Application – Forecast for Cardiology Market (Million US$), 2023 – 2028
- Figure-51: Application – Oncology Market (Million US$), 2018 – 2022
- Figure-52: Application – Forecast for Oncology Market (Million US$), 2023 – 2028
- Figure-53: Application – Nephrology Market (Million US$), 2018 – 2022
- Figure-54: Application – Forecast for Nephrology Market (Million US$), 2023 – 2028
- Figure-55: Application – Autoimmune Diseases Market (Million US$), 2018 – 2022
- Figure-56: Application – Forecast for Autoimmune Diseases Market (Million US$), 2023 – 2028
- Figure-57: Application – Drug Testing Market (Million US$), 2018 – 2022
- Figure-58: Application – Forecast for Drug Testing Market (Million US$), 2023 – 2028
- Figure-59: Application – Other Applications Market (Million US$), 2018 – 2022
- Figure-60: Application – Forecast for Other Applications Market (Million US$), 2023 – 2028
- Figure-61: End User – Hospitals Market (Million US$), 2018 – 2022
- Figure-62: End User – Forecast for Hospitals Market (Million US$), 2023 – 2028
- Figure-63: End User – Laboratories Market (Million US$), 2018 – 2022
- Figure-64: End User – Forecast for Laboratories Market (Million US$), 2023 – 2028
- Figure-65: End User – Home - Care Market (Million US$), 2018 – 2022
- Figure-66: End User – Forecast for Home - Care Market (Million US$), 2023 – 2028
- Figure-67: End User – Others Market (Million US$), 2018 – 2022
- Figure-68: End User – Forecast for Others Market (Million US$), 2023 – 2028
- Figure-69: Roche Diagnostics – Global Revenue (Billion US$), 2018 – 2022
- Figure-70: Roche Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-71: Abbott Diagnostics – Global Revenue (Billion US$), 2018 – 2022
- Figure-72: Abbott Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-73: Siemens Healthineers – Global Revenue (Billion US$), 2018 – 2022
- Figure-74: Siemens Healthineers – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-75: Danaher Corporation – Global Revenue (Billion US$), 2018 – 2022
- Figure-76: Danaher Corporation – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-77: Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
- Figure-78: Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2028
- Figure-79: Sysmex Corporation – Global Revenue (Million US$), 2018 – 2022
- Figure-80: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2023 – 2028
- List of Tables:
- Table-01: Italy – In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2018 – 2022
- Table-02: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Test Types (Percent), 2023 – 2028
- Table-03: Italy – In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2018 – 2022
- Table-04: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Technology (Percent), 2023 – 2028
- Table-05: Italy – In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2018 – 2022
- Table-06: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Products (Percent), 2023 – 2028
- Table-07: Italy – In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2018 – 2022
- Table-08: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by Application (Percent), 2023 – 2028
- Table-09: Italy – In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2018 – 2022
- Table-10: Italy – Forecast for In-Vitro Diagnostics (IVD) Market Share by End User (Percent), 2023 – 2028
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook